NovoCure
NVCR
NVCR
236 hedge funds and large institutions have $1.4B invested in NovoCure in 2024 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $1.37B → $1.4B (+$27.8M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.68% less ownership
Funds ownership: 86.03% → 83.35% (-2.7%)
Holders
236
Holding in Top 10
3
Calls
$29.2M
Puts
$12.6M
Top Buyers
| 1 | +$9.01M | |
| 2 | +$6.6M | |
| 3 | +$6.17M | |
| 4 |
Man Group
London,
United Kingdom
|
+$6.04M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.88M |
Top Sellers
| 1 | -$44.5M | |
| 2 | -$16.9M | |
| 3 | -$15.1M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$14.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.83M |